Barclays PLC ADR (BCS) News
Filter BCS News Items
BCS News Results
|Loading, please wait...|
BCS News Highlights
- For BCS, its 30 day story count is now at 20.
- Over the past 27 days, the trend for BCS's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- The most mentioned tickers in articles about BCS are TOP, PAY and CS.
Latest BCS News From Around the Web
Below are the latest news stories about BARCLAYS PLC that investors may wish to consider to help them evaluate BCS as an investment opportunity.
Barclays Chief Executive C.S. Venkatakrishnan said on Tuesday that his cancer was detected early and is "very localised", meaning that doctors are very optimistic about treating it. The British bank said on Monday that Venkatakrishnan would undergo treatment in New York for non-Hodgkin lymphoma. Barclays has not appointed an interim replacement and said the CEO will stay involved with running it where treatment allows.
The chief executive of Barclays says he has to do a better job convincing investors of the merit of the investment bank as its share price lags behind rivals. CS Venkatakrishnan, speaking in his first interview since he announced he would be undergoing treatment for non-Hodgkin lymphoma, said that he needed to do a better job explaining the model of the unit, as well as eliminating self-inflicted scandals at the British bank’s largest division.
Dismal investment banking performance and rising provisions are expected to have hurt Toronto-Dominion's (TD) fiscal Q4 earnings, while higher interest rates and improved trading might have aided.
Chief Executive Officer C.S. Venkatakrishnan has been diagnosed with non-Hodgkin lymphoma, with treatment expected to last 12 to 16 weeks.
Barclays PLC (NYSE: BCS) CEO, C.S. Venkatakrishnan, informed the Barclays Board and his colleagues that he would be undergoing treatment for Non-Hodgkin Lymphoma. Non-Hodgkin lymphoma is a type of cancer, meaning he would work from home for some time, CNBC reports. The CEO, known inside the bank as Venkat, said in a letter that his condition was curable and that doctors have said his prognosis is “excellent,” with the treatment in New York expected to last 12 to 16 weeks. “During this period, th
Investors need to pay close attention to Barclays (BCS) stock based on the movements in the options market lately.
Barclays has announced that its chief executive, CS Venkatakrishnan, has been diagnosed with non-Hodgkin lymphoma and will be undergoing treatment for the next 12 to 16 weeks. The next most senior executives at the lender are Paul Compton - head of the investment bank, who joined Barclays in 2016 alongside Venkatakrishnan from JPMorgan Chase - and finance director Anna Cross, who sits on the board. Barclays’ chair is veteran Rothschild banker Nigel Higgins.
Yahoo Finance Live anchors discuss a Barclays analyst's decision to downgrade Williams-Sonoma and RH stocks to Equal Weight from Overweight as home goods spending slows.
In this article, we discuss 15 biggest banks in the world. To skip to the top 5 banks in this list, go to 5 Biggest Banks In The World. Ever since the Federal Reserve started increasing interest rates, major banks have been in the limelight as analysts believe these rate hikes are set to benefit […]
HMRC payment went into account number recycled by Barclays and new holder did not return cash